BVD-523,
ulixertinib,
VRT752271,
Ulixertinib,
869886-67-9,
VRT752271,
BVD-523,
UNII-16ZDH50O1U,
Ulixertinib [INN],
Ulixertinib (BVD-523,VRT752271),
Ulixertinib (BVD-523, VRT752271),
16ZDH50O1U,
CHEMBL3590106,
Ulixertinib (INN),
4-[5-chloranyl-2-(propan-2-ylamino)pyridin-4-yl]-~{N}-[(1~{S})-1-(3-chlorophenyl)-2-oxidanyl-ethyl]-1~{H}-pyrrole-2-carboxamide,
4-(5-chloro-2-(isopropylamino)pyridin-4-yl)-N-((S)-1-(3-chlorophenyl)-2-hydroxyethyl)-1H-pyrrole-2-carboxamide,
VRT-752271,
GTPL9210,
SCHEMBL14211742,
ulixertinib-bvd-523-vrt752271,
BCP04232,
EX-A1332,
KS-00000T4A,
N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-4-[5-chloro-2-(propan-2-ylamino)pyridin-4-yl]-1H-pyrrole-2-carboxamide,
BDBM50094465,
s7854,
ZINC34642570,
AKOS025396467,
CS-2115,
SB19723,
NCGC00378692-02,
NCGC00378692-07,
1H-Pyrrole-2-carboxamide, 4-(5-chloro-2-((1-methylethyl)amino)-4-pyridinyl)-N-((1S)-1-(3-chlorophenyl)-2-hydroxyethyl)-,
HY-15816,
QC-10489,
BCP0726000085,
A11794,
D11038,
J-690368,
3,5-Dichloro-2-hydroxy-N-(4-methoxy-3-biphenylyl)benzenesulfonamide,
(S)-4-(5-chloro-2-(isopropylamino)pyridin-4-yl)-N-(1-(3-chlorophenyl)-2-hydroxyethyl)-1H-pyrrole-2-carboxamide,
4-[5-Chloro-2-(isopropylamino)-4-pyridinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamide,
CID11719003,
CID 11640605,
EVK,